GNH USA

Europe — EMA

Metoprolol Retard Teva

GNH USA supplies Metoprolol Retard (Metoprolol Succinate), a beta blocker for hypertension, angina and heart failure. Request a quote for global supply.

Metoprolol Succinate (Ph. Eur.)

Request sourcing

1
Pack/s

What is Metoprolol Succinate (Ph. Eur.)?

Metoprolol succinate, the active ingredient in Metoprolol Retard, is a beta blocker presented as an extended‑release tablet for oral use. It reduces blood pressure, relieves angina, improves heart‑failure symptoms, and lowers the risk of recurrent myocardial infarction in adult patients.

GNH USA supplies Metoprolol Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance across diverse markets.

What is Metoprolol Succinate (Ph. Eur.) used for?

Metoprolol Retard, a selective β1‑adrenergic blocker, is used in cardiovascular conditions that require heart‑rate control and reduced cardiac workload. - Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Chronic heart failure: improves ventricular function and reduces hospitalisation. - Post‑myocardial infarction: lowers the chance of recurrent events and improves survival.

What are the side effects of Metoprolol Succinate (Ph. Eur.)?

Metoprolol Retard may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headed sensation, especially on standing. - Bradycardia: slower than normal heart rate. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe bradycardia or heart block: may require medical attention. - Hypotension: marked drop in blood pressure. - Bronchospasm: tightening of airway muscles, especially in asthmatic patients. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

What precautions apply to Metoprolol Succinate (Ph. Eur.)?

Before prescribing Metoprolol Retard, clinicians should consider several safety aspects. - Dose adjustment in renal impairment: reduce dose as needed based on renal function. - Monitor heart rate: avoid use if resting heart rate is below 60 bpm. - Caution in asthma or COPD: β1‑selectivity may still affect bronchial tone. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

What does Metoprolol Succinate (Ph. Eur.) interact with?

Metoprolol Retard can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective β‑blockers: additive bradycardia. - Calcium channel blockers (verapamil, diltiazem): risk of severe AV block. - Clonidine: possible rebound hypertension if stopped. - Insulin or oral hypoglycemics: may mask hypoglycaemia symptoms.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect. - ACE inhibitors or ARBs: additive blood‑pressure lowering. - SSRIs or other antidepressants: potential increase in bradycardia.

Frequently asked questions

What conditions is Metoprolol Retard used to treat?+
Metoprolol Retard is prescribed for high blood pressure (hypertension), chest pain due to reduced blood flow (angina pectoris), chronic heart failure, and to reduce the risk of further heart attacks after a myocardial infarction. It works by lowering heart rate and cardiac output.
How does metoprolol succinate work in the body?+
Metoprolol succinate selectively blocks β1‑adrenergic receptors in the heart, decreasing the effects of adrenaline and noradrenaline. This leads to a slower heart rate, reduced force of contraction, and lower blood pressure, helping to relieve strain on the cardiovascular system.
What is the usual dose of Metoprolol Retard?+
The appropriate dose of Metoprolol Retard is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the dosage instructions provided by their healthcare professional.
Is Metoprolol Retard safe during pregnancy or breastfeeding?+
Safety data for metoprolol succinate in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.
How do I order Metoprolol Retard from GNH USA?+
To request Metoprolol Retard, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Metoprolol Retard compare with other beta blockers?+
Metoprolol Retard is a β1‑selective blocker formulated as an extended‑release tablet, offering once‑daily dosing and smoother plasma concentrations compared with immediate‑release agents. Compared with non‑selective beta blockers, it has a lower risk of bronchospasm but shares similar cardiovascular effects.
What are the storage requirements for Metoprolol Retard?+
Metoprolol Retard should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Do not store in a bathroom or near heat sources.
How is Metoprolol Retard administered?+
Metoprolol Retard is taken orally as a whole extended‑release tablet, usually once daily with or without food. The tablet should not be split, chewed, or crushed, as this can alter the release profile and affect efficacy.
What are the most serious risks associated with Metoprolol Retard?+
Serious risks include severe bradycardia, marked hypotension, heart block, bronchospasm in patients with reactive airway disease, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience fainting, severe dizziness, or breathing difficulties.
Who should not use Metoprolol Retard?+
Metoprolol Retard is contraindicated in patients with known hypersensitivity to metoprolol or any component of the formulation, in those with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, and in patients experiencing cardiogenic shock.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Metoprolol Succinate (Ph. Eur.)
Route
Oral Use
Manufacturer
Teva Pharma Belgium N.V./S.A
Origin
EU

Related products